|
Functional and Structural Optical Brain Imaging
|
Research Initiative
|
FDA
|
NICHD
|
Functional and Structural Optical Brain Imaging
|
|
Funding Opportunity Announcement Module (FOAM)
|
Resource Development
|
ACF, ACL, AHRQ, CDC, CMS, FDA
|
OD/OER, CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/AoU, OD/DPCPSI, OD/DPCPSI/OAR, OD/DPCPSI/OBSSR, OD/DPCPSI/ODS, OD/DPCPSI/ORIP, OD/DPCPSI/ORWH, OD/DPCPSI/OSC, OD/DPCPSI/THRO, OD/DPCPSI/SGMRO, OD/ECHO, OD/IMOD, OD/OCPL, OD/OIR, OD/OIR/OTT, OD/OLPA, OD/OM/OB, OD/ORS, OD/OSP
|
The Funding Opportunity Announcement Module (FOAM) allows National Institutes of Health (NIH) Institutes and Centers and Department of Health and Human Services (HHS) Operating Divisions to develop content for and perform the needed approvals to publish funding opportunity announcements. The system has a flexible configuration to meet all of the needs for HHS Operating Divisions. In addition FOAM serves as a Federal Shared Service in collaboration with Grant Solutions supporting other agencies including Department of the Interior, Department of Housing and Urban Development, and Department of Homeland Security. FOAM achieves economies of scale by preventing the need for individual agencies to develop duplicate systems at a cost much greater than that of developing a unified system.
|
|
FY 22 Ending the HIV Epidemic in the US Funding Opportunity Announcement
|
Research Initiative
|
CDC, HRSA
|
NIAID, NIMH, NIDA
|
Three NIH EHE RFAs supports locally defined and culturally sensitive research projects that address the four key pillars of the EHE initiative (Diagnose, Treat, Prevent, and Respond). Specifically the NIH supports investigators in one of the 57 priority jurisdictions to work with implementing partners to develop and test locally defined and culturally sensitive solutions that align with jurisdictional EHE plans. CDC and HRSA provided key support in the development of the research topics.
|
|
Gabriella Miller Kids First Common Fund Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NICHD, NCI, NEI, NHGRI, NHLBI, NIAAA, NIAMS, NIDA, NIDCR, NIDDK, NIEHS, NINDS, OD/DPCPSI/ORIP
|
The National Institutes of Health (NIH) Gabriella Miller Kids First Common Fund Working Group supports the goals and initiatives of the NIH Gabriella Miller Kids First Common Fund Pediatric Research Program (Kids First). Kids First is developing a data resource for the pediatric research community of well-curated clinical and genetic sequence data that will allow scientists to identify genetic pathways that underlie specific pediatric conditions but that may also be shared between apparently disparate conditions. A representative from the Centers for Disease Control and Prevention (CDC) participates in the Kids First Working Group.
|
|
Gender Policy Council: HHS Women's Health & Rights Working Group
|
Committee, Work group, Advisory group, or Task Force
|
SAMHSA, HRSA, CDC, OGA, OASH
|
NICHD
|
This working group is tasked to develop a Government-Wide Strategy to Advance Gender Equity and Equality with respect to women's health and rights.
|
|
Genetic Epidemiology of Diabetes and Obesity
|
Research Initiative
|
IHS
|
NIDDK
|
Genetic Epidemiology of Diabetes and Obesity
|
|
Genetic Epidemiology of Diabetic Complications
|
Research Initiative
|
IHS
|
NIDDK
|
Genetic Epidemiology of Diabetic Complications
|
|
Genetic Studies in the National Birth Defects Prevention Study (NBDPS)
|
Research Initiative
|
CDC
|
NHGRI
|
This study is a collaboration between The Centers for Disease Control and Prevention (CDC) and the National Human Genome Research Institute (NHGRI) to carry out DNA sequencing and genotyping on samples collected as part of the National Birth Defects Prevention Study.
|
|
Genital Herpes Workshop
|
Meeting/ Workshop
|
CDC
|
NIAID
|
This workshop was co-sponsored by NIAID and CDC to review the status of research, product development, and education on genital herpes.
|
|
Genome in a Bottle Consortium (GIAB)
|
Resource Development
|
CDC, FDA
|
NLM, NHGRI, NCI
|
The "Genome in a Bottle Consortium" was organized to develop the reference materials, reference data, and reference methods needed to assess performance of human genome sequencing. It is a public-private-academic consortium hosted by NIST to develop the technical infrastructure (reference standards, reference methods, and reference data) to enable translation of whole human genome sequencing to clinical practice and innovations in technologies. The priority of GIAB is authoritative characterization of human genomes for use in benchmarking, including analytical validation and technology development, optimization, and demonstration.
|